CGTX Earnings

CGTX reported its FY2025Q2 earnings on 2025-08-07, showcasing a revenue of 0.00 against an estimate of 21.00M, resulting in a -100% surprise. The EPS was -0.11, surpassing the expected -0.12 by 8.33% . The stock experienced a -4.78% price change on the earnings day and a 54.71% change over the next five days, reflecting market reactions to the results.

Following CGTX's FY2025Q2 earnings announcement on 2025-08-07, the stock price moved by -4.78% on the day of the release. Over the subsequent five days, it saw a 54.71% change. Historically, CGTX's stock price tends to shift by an average of +6.75% in the 10 days leading up to earnings and +17.05% in the 10 days following, providing insight into potential market.

For , analysts estimate CGTX’s annual revenue to reach undefined, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -23.53% and EPS estimates No Change by % over the past three months, indicating analyst expectation in the company’s performance.

The correlation between CGTX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -23.53%, while EPS estimates moved No Change by % . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CGTX's stock price typically moves by +6.75% in the 10 days before its earnings and +17.05% in the 10 days after. For the upcoming earnings, analysts expect an EPS of 0.00 and revenue of undefined.

The earnings call summary reveals several concerns: missed EPS expectations, significant financial losses, NASDAQ compliance risks, and the need for substantial capital. Despite some positive feedback from KOLs and ongoing FDA discussions, the Q&A section highlights uncertainties in clinical strategies and funding. The absence of clear guidance and the sale of shares via ATM further dampen sentiment. Overall, these factors suggest a negative stock price movement in the short term.